SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

More documents

Recommendations

Info

P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 Signorile, JF and Roos, BA. Resistance training for power, strength, and functionality: a longterm prescription. Australian Journal of Medical Science 398-402, Sept/Oct, 2002. Hernandez-Cassis, C, Vogel, CK, Hernandez, TP, Econs, MJ, Iglesias, M, Iglesias, A, Levis, S, Roos, BA, Howard, GA, and Gamarra, AI. Autosomal dominant hyperostosis/osteosclerosis with high serum alkaline phosphatase activity. Journal of Clinical Endocrinology and Metabolism 88:2650-55, 2003. Penedo, FJ, Dahn, JR, Gonzalez, JS, Molton, I, Carver, CS, Antoni, MH, Roos, BA, and Schneiderman, N. Perceived stress management skill mediates the relationship between optimism and positive mood following radical prostatectomy. Health Psychology 22:220-22, 2003. Lancet, JE, Rosenblatt, JD , and Karp, JE. Farnesyltransferase inhibitors and myeloid malignancies: phase I evidence of Zarnestra activity in high-risk leukemias. Seminars in Hematology 39:31-35, 2002. Tolba, KA, Bowers, WJ, Muller, J, Housekneckt, V, Giuliano, RE, Federoff, HJ, and Rosenblatt, JD. Herpes simplex virus (HSV) amplicon-mediated codelivery of secondary lymphoid tissue chemokine and CD40L results in augmented antitumor activity. Cancer Research 62:6545- 51, 2002. Rosenblatt, JD , Shin, SU, Nechustan, H, Yi, KH, and Tolba, K. Potential role of chemokines in immune therapy of cancer. Israel Medical Association Journal 4:1054-59, 2002. Tolba, KA, Bowers, WJ, Eling, DJ, Casey, AE, Kipps, TJ, Federoff, HJ, and Rosenblatt, JD . HSV amplicon mediated delivery of LIGHT enhances the antigen-presenting capacity of chronic lymphocytic leukemia. Molecular Therapy 6:455-63, 2002. Andela, VB, Rosenblatt, JD , Schwarz, EM, Puzas, EJ, O’Keefe, RJ, and Rosier, RN. Synergism of aminobisphosphonates and farnesyl transferase inhibitors on tumor metastasis. Clinical Orthopaedics and Related Research 397:228-39, 2002. Khorana, AA, Rosenblatt, JD , Sahasrabudhe, DM, Evans, T, Ladrigan, M, Marquis, D, Rosell, K, Whiteside, T, Phillippe, S, Acres, B, Slos, P, Squiban, P, Ross, M, and Kendra, K. A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma. Cancer Gene Therapy 10:251-9, 2003. Andela, VB, Pirri, M, Schwarz, EM, Puzas, EJ, O’Keefe, RJ, Rosenblatt, JD, and Rosier, RN. The mevalonate synthesis pathway as a therapeutic target in cancer. (Review) Clinical Orthopaedics 415 (Supplement):S59-66, 2003. Liesveld, JL, Lancet, JE, Rosell, KE, Menon, A, Lu, C, McNair, C, Abboud, CN, and Rosenblatt, JD. Effects of the farnesyl transferase inhibitor R115777 on normal and leukemic hematopoiesis. Leukemia 17:1806-12, 2003. Rosenblatt, JD and Harrington, WJ Jr. Leukemia and myelopathy: the persistent mystery of pathogenesis by HTLV-I/II. Cancer Investigation 21:323-24, 2003. Yang, X, Salas, PJ , Pham, TV, Wasserlauf, BJ, Smets, MJ, Myerburg, RJ, Gelband, H, Hoffman, BF, and Bassett, AL. Cytoskeletal actin microfilaments and the transient outward potassium current in hypertrophied rat ventriculocytes. Journal of Physiology 541: 411-21, 2002. Figueroa, Y, Wald, FA, and Salas, PJ . p34cdc2- mediated phosphorylation mobilizes microtubule-organizing centers from the apical intermediate filament scaffold in CACO-2 epithelial cells. Journal of Biological Chemistry 277:37848-54, 2002. UM/Sylvester Comprehensive Cancer Center Scientific Report 2004 181
P U B L I C A T I O N S 2 0 0 2 - 2 0 0 3 Ramsauer, VP, Carothers Carraway, CA, Salas, PJ, and Carraway, KL. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, translocates ErbB2 to the apical surface in polarized epithelial cells. Journal of Biological Chemistry 278:30142-47, 2003. Ameen, NA, Marino, C, and Salas, PJ . cAMPdependent exocytosis and vesicle traffic regulate CFTR and fluid transport in rat jejunum in vivo. American Journal of Physiology: Cell Physiology 284:C429-38, 2003. Wald, FA, Figueroa, Y, Oriolo, AS, and Salas, PJ . Membrane repolarization is delayed in proximal tubules after ischemia-reperfusion: possible role of microtubule-organizing centers. American Journal of Physiology: Renal Physiology 285:F230-40, 2003. Feun, LG, Modiano, M, Lee, K, Mao, J, Marini, A, Savaraj, N, Plezia, P, Almassian, B, Colacino, E, Fischer, J, and MacDonald, S. Phase I and pharmacokinetic study of 3-aminopyridine-2- carboxaldehyde thiosemicarbazone (3-AP) using a single intravenous dose schedule. Cancer Chemotherapy and Pharmacology 50:223-29, 2002. Wangpaichitr, M, Landy, H, Wu, CJ, Feun, LG, Xu, R, Xu, J, and Savaraj, N. Procollagen-like protein as a molecular target in the treatment of primary brain tumor. Scientific World Journal. 2:125-26, 2002 Feun LG, Savaraj N, Hurley J, and Marini A. Phase II trial of paclitaxel and dacarbazine with filgrastim administration in advanced malignant melanoma. Cancer Investigation 20:357-61, 2002. Liu, H, Savaraj, N, Priebe, W, and Lampidis, TJ. Hypoxia increases tumor cell sensitivity to glycolytic inhibitors: a strategy for solid tumor therapy (Model C). Biochemical Pharmacology 64:1745- 51, 2002. Feun, LG, O’Brien, C, Molina, E, Rodriguez, M, Jeffers, L, Schiff, ER, Marini, A, Savaraj, N, and Ardalan, B. Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma—a phase II trial. Journal of Cancer Research and Clinical Oncology 129:17- 20, 2003. Robles, C, Furst, AJ, Sriratana, P, Lai, S, Chua, L, Donnelly, E, Solomon, J, Sundaram, M, Feun, LG, and Savaraj, N. Phase II study of vinorelbine with low dose prednisone in the treatment of hormone-refractory metastatic prostate cancer. Oncology Report 10:885-89, 2003. Savaraj, N, Wu, C, Wangpaichitr, M, Kuo, MT, Lampidis, TJ, Robles, C, Furst, AJ, and Feun, LG. Overexpression of mutated MRP4 in cisplatin resistant small-cell lung cancer cell line: collateral sensitivity to azidothymidine. International Journal of Oncology 23:173-9, 2003. Hu, YP, Haq, B, Carraway, KL, Savaraj, N, and Lampidis, TJ. Multidrug resistance correlates with overexpression of Muc4 but inversely with P-glycoprotein and multidrug resistance related protein in transfected human melanoma cells. Biochemical Pharmacology 65:1419-25, 2003. Walker, GR, Schlesselman, JJ , and Ness, RB. Family history of cancer, oral contraceptive use, and ovarian cancer risk. American Journal of Obstetrics and Gynecology 186:8-14, 2002. Sofer, M, Hamilton-Nelson, KL, Schlesselman, JJ, and Soloway, MS. Risk of positive margins and biochemical recurrence in relation to nervesparing radical prostatectomy. Journal of Clinical Oncology 20:1853-8, 2002. Collins, JA and Schlesselman, JJ . Perimenopausal use of reproductive hormones effects on breast and endometrial cancer. Obstetrics and Gynecology Clinics of North America 29:511-25, 2002. Schlesselman, JJ and Collins, JA. Evaluating systematic reviews and meta-analyses. Seminars in Reproductive Medicine 21:95-106, 2003. 182 UM/Sylvester Comprehensive Cancer Center Scientific Report 2004
Page 1 and 2:
S C I E N T I F I C R E P O R T 2 0
Page 3 and 4:
I N T R O D U C T I O N A N D P R O
Page 5 and 6:
Page 7 and 8:
Page 9 and 10:
Page 11 and 12:
L E A D E R S H I P MULTIDISCIPLINA
Page 13 and 14:
L E A D E R S H I P EXTERNAL ADVISO
Page 15 and 16:
C A N C E R P R E V E N T I O N A N
Page 17 and 18:
Page 19 and 20:
Page 21 and 22:
Page 23 and 24:
Page 25 and 26:
Page 27 and 28:
Page 29 and 30:
Page 31 and 32:
Page 33 and 34:
Page 35 and 36:
Page 37 and 38:
Page 39 and 40:
Page 41 and 42:
Page 43 and 44:
Page 45 and 46:
Page 47 and 48:
C L I N I C A L O N C O L O G Y R E
Page 49 and 50:
Page 51 and 52:
Page 53 and 54:
Page 55 and 56:
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
T U M O R C E L L B I O L O G Y P R
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
T U M O R I M M U N O L O G Y P R O
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144: V I R A L O N C O L O G Y P R O G R
Page 157 and 158: S H A R E D R E S O U R C E S 3) La
Page 159 and 160: S H A R E D R E S O U R C E S C E L
Page 161 and 162: S H A R E D R E S O U R C E S D N A
Page 163 and 164: S H A R E D R E S O U R C E S G E N
Page 165 and 166: S H A R E D R E S O U R C E S I N F
Page 167 and 168: S H A R E D R E S O U R C E S P O P
Page 169 and 170: P U B L I C A T I O N S 2 0 0 2 - 2
Page 193: P U B L I C A T I O N S 2 0 0 2 - 2
Page 205 and 206: G L O S S A R Y IFN—interferon IL
show all

SCIENTIFIC REPORT 2004 - Sylvester Comprehensive Cancer Center

Create successful ePaper yourself

Delete template?

Save as template?